NewsBenzingaAurinia Pharmaceuticals: utile per azione del terzo trimestre di 0,23 $ supera la stima di 0,22 $, ricavi di 83,699 milioni di $ superano la stima di 83,691 milioni di $ Aurinia Pharmaceuticals: utile per azione del terzo trimestre di 0,23 $ supera la stima di 0,22 $, ricavi di 83,699 milioni di $ superano la stima di 83,691 milioni di $ Benzinga 2026.10.30 12:06 (GMT+0) Open on Benzinga Other news Ramp in Talks to Raise at Least $1 Billion at Valuation of Up to $75 Billion How Everyday Investors Are Playing the Nvidia Drama Curve: Fee Conversion Contract Loses $38.2K in Attack, Disabled With Replacement Planned Alvotech (ALVO) Presents at UBS Global Biopharma Conference 2026 Transcript Nvidia Tops Sales Forecast After Huang's Resignation Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares
Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares